Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - DE
$ 4.22
-3.87 %
$ 1.5 B
Market Cap
-8.27
P/E
Price Target
Average
136.97%
Revenue Forecast
Estimate
22.34%
EBIT
Estimate
46.12%
Net Income
Estimate
40.31%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Evotec SE
Wall Street analysts predict an average 1-year price target for EVO of $10 , with forecasts ranging from
a
low of
$8 to a high of $12 .
EVO Lowest Price Target
Wall Street Target
8 USD
89.57%
EVO Average Price Target
Wall Street Target
10 USD
136.97%
EVO Highest Price Target
Wall Street Target
12 USD
184.36%
REVENUE FORECAST
Revenue Forecast Chart EVO
EBIT FORECAST
EBIT Forecast Chart EVO
NET INCOME FORECAST
Net Income Chart EVO